Skip to main content

Pharma News

 

Clinical courses

 

Clinical research courses

  • Artificial Intelligence (AI) in Pharma - Which are Jobs for Pharmacy professionals

    Do you think the Healthcare Sector of India is ready and has the ability to adopt the AI (Artificial Intelligence) future?

    - Has AI helped in combating the whole COVID-19 pandemic
    - How is AI aiding Clinical Research
    - How pharmacy student should be prepared for the AI future
    - Jobs available for the students in Pharma sector

  • AI based technology found answer of 50 years old mystery of Protein

    Proteins are essential to life, supporting practically all its functions. They are large complex molecules, made up of chains of amino acids, and what a protein does largely depends on its unique 3D structure. Figuring out what shapes proteins fold into is known as the “protein folding problem”, and has stood as a grand challenge in biology for the past 50 years. The latest version of Google Deepmind’s AI system AlphaFold has been recognised as a solution to this grand challenge by the organisers of the biennial Critical Assessment of protein Structure Prediction (CASP). This breakthrough demonstrates the impact AI can have on scientific discovery.

  • FUTURE PERSPECTIVE OF DIGITAL LEARNING IN INDIA

    The live interaction session on theme Future Perspective of DIGITAL LEARNING in India was organized on 6th May, 2020 (Wednesday), 5:00 PM-6:30 PM.

    The Session was successfully convened by Dr. Neelesh Malviya, Principal and Professor, Smriti College of Pharmaceutical Education, Indore.

  • Sun Pharma launches FluGuard® (Favipiravir) in India at Rs. 35 per tablet

    Sun Pharma announced that it has launched FluGuard® (Favipiravir 200 mg) at an economical price of Rs. 35 per tablet, for the treatment of mild to moderate cases of Covid-19 in India. Favipiravir is the only oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate Covid-19 disease.

  • Career for Scientific Officer B (Sanger Sequencing Facility) in NCBS

    National Centre for Biological Sciences (NCBS), Tata Institute for Fundamental Research (TIFR) a premier research Centre under the aegis of Department of Atomic Energy, Government of India, is looking for filling up of the following position:

    Post: Scientific Officer B (Sanger Sequencing Facility) (Unreserved)

  • FDA approves JUVEDERM VOLUMA XC for enhancement of the Chin Region

    Allergan Aesthetics got the FDA approval of JUVÉDERM® VOLUMA™ XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21. As the category leader, the JUVÉDERM® collection of Fillers has the broadest portfolio of specifically tailored treatment options, and this latest approval marks their fifth approved indication in the U.S.

  • Apply online for Pharmacist at National AIDS Research Institute

    ICMR-NARI is located at Bhosari, Pune on a seven acre plot. Since its inception the Institute has ably supported the National AIDS Control Programme, especially in the areas of surveillance, capacity building, laboratory services and drug resistance studies. ICMR-NARI derives strength from wide ranging National and International Collaborations.

  • Job for Production Department Troikaa Pharmaceuticals Ltd

  • Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications

    COVID-19 can cause serious cardiovascular complications including heart failure, heart attacks and blood clots that can lead to strokes, emergency medicine doctors report in a new scientific paper. They also caution that COVID-19 treatments can interact with medicines used to manage patients' existing cardiovascular conditions.

  • US based Sorrento Therapeutics claims breakthrough against COVID-19, shares jumps around 244 percent

    San Diego based Sorrento Therapeutics claims that its anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration which lead to jumps in stocks around 244%.

Subscribe to Pharma News